Significance of eGFR and proteinuria for cardiovascular disease in individuals beyond 85 years of age

Author:

Azegami Tatsuhiko1,Kaneko Hidehiro23ORCID,Okada Akira4,Suzuki Yuta25,Fujiu Katsuhito23,Morita Hiroyuki2,Takeda Norifumi2,Takeda Norihiko2,Fukui Akira6,Yokoo Takashi6,Node Koichi7ORCID,Yasunaga Hideo8,Nangaku Masaomi9ORCID,Hayashi Kaori1

Affiliation:

1. Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine , Tokyo , Japan

2. Department of Cardiovascular Medicine, The University of Tokyo , Tokyo , Japan

3. Department of Advanced Cardiology, The University of Tokyo , Tokyo , Japan

4. Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo , Tokyo , Japan

5. Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health , Saitama , Japan

6. Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine , Tokyo , Japan

7. Department of Cardiovascular Medicine, Saga University , Saga , Japan

8. Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo , Tokyo , Japan

9. Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine , Tokyo , Japan

Abstract

ABSTRACT Background There are limited data on how advancing age influences prediction of cardiovascular disease (CVD) risk based on the estimated glomerular filtration rate (eGFR) and proteinuria, especially in older adults, including those aged ≥85 years old. This study aimed to clarify the association of eGFR and proteinuria with CVD outcomes and the impact of age on this association. Methods The distribution of eGFR and urine protein in Japan was assessed retrospectively using real-world administrative claims and health checkup data collected between April 2014 and November 2022. We investigated the associations of these two parameters with the incidence of CVD, with an emphasis on the impact of aging. Results We assessed 1 829 020 individuals for distribution of eGFR and proteinuria; after excluding those with known CVD, their association with CVD risk was examined in 1 040 101 individuals aged ≥40 years. The prevalence of impaired kidney function (eGFR <60 mL/min/1.73 m2) increased with age, being 0.7%, 9.2%, 21.9%, 40.2% and 60.2% at the ages of 18–39, 40–64, 65–74, 75–84 and ≥85 years, respectively (P for trend <.001); similarly, the proportion with positive proteinuria increased with age, being 2.7%, 4.3%, 5.6%, 9.2% and 15.8%, respectively (P for trend <.001). Both eGFR and urine protein were identified to be independent risk factors for CVD. Hazard ratios for CVD increased significantly when eGFR was <45 mL/min/1.73 m2 at the ages of 40–64, 65–74 and 75–84 years and <30 mL/min/1.73 m2 at ≥85 years, while proteinuria remained significantly associated with a high CVD risk regardless of age. These findings were consistent even when analyzed separately by sex. Conclusions This study identified eGFR and urine dipstick proteinuria to be independent risk factors for CVD, even among individuals aged ≥85 years. However, the contribution of eGFR to the CVD risk was attenuated by aging, whereas proteinuria remained less affected by advancing age.

Funder

Ministry of Health, Labour and Welfare, Japan

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Oxford University Press (OUP)

Reference24 articles.

1. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N Engl J Med,2004

2. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;GBD Chronic Kidney Disease Collaboration;Lancet North Am Ed,2020

3. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community;Manjunath;J Am Coll Cardiol,2003

4. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward;Levin;Kidney Int,2014

5. Accounting for age in the definition of chronic kidney disease;Liu;JAMA Intern Med,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3